AVEO Pharmaceuticals (AVEO) jumps as EU gives go-ahead

AVEO Pharmaceuticals, Inc. AVEO shares rose 11.6% to $2.59 after the company received the EU regulatory guidance regarding potential MAA for Tivozanib. Share volume was 13 million, compared to an all-day average of 3.8 million